Drug Landscape ›
ibuprofen and codeine ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 10
Most-reported reactions
Asthenia — 1 report (10%) Cellulitis — 1 report (10%) Contraindicated Product Administered — 1 report (10%) Drug Abuse — 1 report (10%) Drug Dependence — 1 report (10%) Dyspnoea — 1 report (10%) Incorrect Dose Administered — 1 report (10%) Pain In Jaw — 1 report (10%) Platelet Count Decreased — 1 report (10%) Product Monitoring Error — 1 report (10%)
Source database →
ibuprofen and codeine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is ibuprofen and codeine approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for ibuprofen and codeine in United States?
St. Justine's Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.